Global Geriatric Medicine Market Valued at $177.6 billion in 2025, Set to Grow at a 7.0% CAGR

Geriatric medicine market was valued at $177.6 billion in 2025 and is projected to reach $348.6 billion by 2035, growing at a CAGR of 7.0% during the forecast Period (2026-2035). Investment in integrated geriatric care is increasingly driving the expansion of specialized eldercare infrastructure, enhancing access to comprehensive medical and therapeutic solutions for the aging population. Such initiatives not only support improved healthcare delivery but also stimulate demand for geriatric medicines and therapies addressing age-related conditions. For instance, in January 2025, Geri Care Health Services secured a $13?million investment from healthcare private equity investor InvAscent through India Life Sciences Fund IV, aimed at expanding its integrated geriatric care services across key South Indian cities and building specialty eldercare centres.

Browse the full report description of “Geriatric Medicine Market Size, Share & Trends Analysis by Therapeutics (Analgesics, Antihypertensive, Statins, Antidiabetic, Proton Pump Inhibitors (PPIs), Anticoagulants, Antipsychotics, and Others), By Condition (Cardiovascular Diseases, Arthritis & Bone Health, Neurological Disorders, Cancer (Geriatric Oncology), Diabetes & Metabolic Disorders, Respiratory Diseases, and Others), and By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/geriatric-medicine-market

Expansion of Specialized Eldercare Infrastructure to Enhance Geriatric Services

• In March 2026, KITES Senior Care invested $4.4 million to expand its specialized elder-care infrastructure, aiming to increase its capacity from over 450 to 1,000 beds. This expansion will enhance access to geriatric care services in urban areas such as Bangalore, Chennai, Hyderabad, and Pune. KITES currently operates centres in several Indian cities and has previously invested $3.3 million in establishing these centres. The new funds focused on increasing clinical staffing capabilities, specialist training, and standardized care protocols for future growth.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Therapeutics
  • By Condition
  • By Distribution Channel
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - AbbVie Inc., AstraZeneca PLC, Merck & Co., Inc., Novartis AG, Pfizer Inc., among others

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Geriatric Medicine Market Report Segment

By Therapeutics

• Analgesics
• Antihypertensive
• Statins
• Antidiabetic
• Proton Pump Inhibitors (PPIs)
• Anticoagulants
• Antipsychotics
• Others

By Condition

• Cardiovascular Diseases
• Arthritis & Bone Health
• Neurological Disorders
• Cancer (Geriatric Oncology)
• Diabetes & Metabolic Disorders
• Respiratory Diseases
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Geriatric Medicine Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/geriatric-medicine-market